Scientists test world’s first Nipah virus vaccine

Oxford scientists said that they are assessing whether the technology behind their COVID-19 jab could be used to protect people from the deadly Nipah virus.
If clinical trials are successful, it would be the first ever vaccine for the disease.
Over the last week, people have begun receiving the jab at the University of Oxford as part of the first human trial of the new vaccine.
COVID vaccine developer, Prof. Dame Sarah Gilbert, said that work on the Nipah vaccine started in 2017 and was paused during the COVID-19 crisis.
The scientists noted that the outbreaks of the Nipah virus had mostly been found in South Asia and the virus can be fatal in up to 75 per cent of cases.
Nipah virus can be transmitted to humans from animals, such as bats or pigs, or contaminated foods and can also be transmitted directly from human-to-human.
In humans it can cause acute respiratory infection and fatal encephalitis (swelling of the brain).
The virus was first identified 25 years ago but there were currently no treatments or vaccines available to help when outbreaks emerge.
But the new vaccine, ChAdOx1 NipahB, could be the first if it reaches safety and efficacy expectations.
Some 51 people aged 18 to 55 would participate in the trial, which is being led by the Oxford Vaccine Group and is being funded by the Coalition for Epidemic Preparedness Innovations.
The jab was developed using the same “viral vector” vaccine technology found in the University of Oxford and AstraZeneca’s COVID-19 vaccine.
The project would run for 18 months, with further trials expected to follow in a Nipah-affected country.
Principal investigator at the University of Oxford’s Pandemic Sciences Institute, Dame Sarah, said, “The University of Oxford’s work on the Nipah virus vaccine started in 2017, but was paused during the COVID-19 pandemic.
“Our work developing the COVID-19 vaccine will now help us prepare this Nipah vaccine for licensure, ensuring we’re ready to prevent future outbreaks of this devastating disease from spreading.’’
Professor Brian Angus, the trial’s principal investigator and professor in infectious diseases at the University of Oxford, said, “Nipah virus was first identified in 1998, and yet 25 years on the global health community still has no approved vaccines or treatments for this devastating disease.
“Due to the high mortality rate and the nature of Nipah virus transmission, the disease is identified as a priority pandemic pathogen. This vaccine trial is an important milestone in identifying a solution that could prevent local outbreaks occurring, while also helping the world prepare for a future global pandemic.’’
Dr In-Kyu Yoon, acting executive director of vaccine research and development at CEPI, added, “Nipah has epidemic potential, with its fruit bat hosts found in areas home to over 2 billion people. This trial is a step forward in efforts to build a suite of tools to protect against this killer virus. Knowledge gained could also inform development of other Paramyxovirus countermeasures.’’
(dpa/NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette

States
Independence: NBA urges Nigerians to expect better future
The NBA said that ordinary Nigerians should be deriving benefit from the subsidy removal rather than hardship.

Agriculture
FG tasks ECOWAS on leveraging financing strategies for agroecology
The federal government has urged stakeholders in the agriculture and finance sectors in the West Africa region to leverage financing strategies to enhance agroecology practices

Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”

NationWide
Ignore police report, treat gunshot victims, IGP Disu tells hospitals
The IGP also urged police officers and medical personnel to uphold the law so they do not discourage members of the public from seeking medical assistance for injured persons.
![Delta Governor, RT. Hon Sheriff Oborevwori [Photo: Facebook/ Sheriff]](https://gazettengr.com/wp-content/uploads/Delta-Governor-RT.-Hon-Sheriff-Oborevwori-Facebook-Sheriff-4.png)
States
Stop using other people’s children as thugs, Oborevwori warns politicians
While reiterating his commitment to peaceful political participation in the state, Mr Oborevwori appealed for responsible political leadership.

States
IKEDC blames power outages in Lagos communities on reduced grid allocation
IKEDC said stakeholders across the power value chain were working to address the challenges responsible for the inadequate electricity supply.

Education
First Lady donates 370,000 sanitary pads to Ebonyi female students
Mrs Tinubu said that providing sanitary pads to schoolgirls aimed to protect the dignity of the girl child and support their well-being.

Anti-Corruption
Katsina court jails man 14 years for defrauding 53 people of millions
The judge sentenced him to seven years’ imprisonment on each count, with no option of a fine. The sentences are to run concurrently.

Lagos
Police meet family of Nigerian-Canadian man killed in Lagos traffic
The police command at the Lagos airport has traced the family of Abraham Osakpolor, a Nigerian-Canadian killed in a road crash.





